Common Contracts
4 similar null contracts by Hancock Jaffe Laboratories, Inc., Pingtan Marine Enterprise Ltd.
Pingtan Marine Enterprise Ltd. 18/F, Zhongshan Building A No. 154 Hudong Road Fuzhou, PRC 350001 Attn: LiMing Yung, Chief Financial Officer Dear Mr. Yung:Pingtan Marine Enterprise Ltd. • March 8th, 2021 • Fishing, hunting and trapping • New York
This letter (the “Agreement”) constitutes the agreement between Spartan Capital Securities, LLC (“Spartan” or the “Placement Agent”) and Pingtan Marine Enterprise Ltd. (the “Company”), that Spartan shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with any offering (each, a “Placement”) of securities of the Company during the Term (as hereinafter defined) of this Agreement. The terms of each Placement and the securities issued in connection therewith shall be mutually agreed upon by the Company and Spartan and nothing herein implies that Spartan would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any securities. The proposed Placement of securities is comprised of registered shares (the “Registered Shares”) of the Company’s ordinary shares, par value $0.001 per share (the “Ordinary Shares”) and registered Warrants to purchase Ordinary Shares (t
Pingtan Marine Enterprise Ltd. 18/F, Zhongshan Building A No. 154 Hudong Road Fuzhou, PRC 350001 Attn: LiMing Yung, Chief Financial Officer Dear Mr. Yung:Pingtan Marine Enterprise Ltd. • January 7th, 2021 • Fishing, hunting and trapping • New York
This letter (the “Agreement”) constitutes the agreement between Spartan Capital Securities, LLC (“Spartan” or the “Placement Agent”) and Pingtan Marine Enterprise Ltd. (the “Company”), that Spartan shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with in any offering (each, a “Placement”) of securities of the Company during the Term (as hereinafter defined) of this Agreement. The terms of each Placement and the securities issued in connection therewith shall be mutually agreed upon by the Company and Spartan and nothing herein implies that Spartan would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any securities. The initial proposed Placement of securities is comprised of registered shares (the “Preferred Shares”) of the Company’s Series A Convertible Preferred Shares, par value $0.001 per share, convertible into the Company’s ordinary share
Hancock Jaffe Laboratories, Inc.Hancock Jaffe Laboratories, Inc. • June 3rd, 2020 • Surgical & medical instruments & apparatus • New York
Hancock Jaffe Laboratories, Inc.Hancock Jaffe Laboratories, Inc. • April 28th, 2020 • Surgical & medical instruments & apparatus • New York
